Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by Gilead Sciences
Information provided by (Responsible Party):
Gilead Sciences Identifier:
First received: July 25, 2012
Last updated: June 30, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2019
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)